Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis
Authors
Keywords
-
Journal
SCHIZOPHRENIA BULLETIN
Volume 42, Issue 6, Pages 1418-1437
Publisher
Oxford University Press (OUP)
Online
2016-05-25
DOI
10.1093/schbul/sbw058
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Promise of Psychiatric Pharmacogenomics
- (2015) Steven P. Hamilton BIOLOGICAL PSYCHIATRY
- Safety and tolerability of antipsychotic-mood stabilizer co-treatment in the management of acute bipolar disorder: results from a systematic review and exploratory meta-analysis
- (2015) Britta Galling et al. Expert Opinion On Drug Safety
- Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder
- (2015) Christoph U. Correll et al. World Psychiatry
- Cardiovascular and cerebrovascular risk factors and events associated with second-generation antipsychotic compared to antidepressant use in a non-elderly adult sample: results from a claims-based inception cohort study
- (2015) Christoph U. Correll et al. World Psychiatry
- Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
- (2015) MARC DE HERT et al. World Psychiatry
- Fat-mass and obesity-associated gene polymorphisms and weight gain after risperidone treatment in first episode schizophrenia
- (2014) Xueqin Song et al. Behavioral and Brain Functions
- Fat Mass- and Obesity-Associated (FTO) Gene and Antipsychotic-Induced Weight Gain: An Association Study
- (2014) Emily C. Shing et al. NEUROPSYCHOBIOLOGY
- Hormonal regulation of the hypothalamic melanocortin system
- (2014) Jung D. Kim et al. Frontiers in Physiology
- MC4R rs489693: a clinical risk factor for second generation antipsychotic-related weight gain?
- (2013) Fabian Czerwensky et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Methylenetetrahydrofolate reductase (MTHFR) 677C/T polymorphism is associated with antipsychotic-induced weight gain in first-episode schizophrenia
- (2013) Umarat Srisawat et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Association Between Common Variants Near the Melanocortin 4 Receptor Gene and Severe Antipsychotic Drug–Induced Weight Gain
- (2012) Anil K. Malhotra ARCHIVES OF GENERAL PSYCHIATRY
- The obesity risk gene FTO influences body mass in chronic schizophrenia but not initial antipsychotic drug-induced weight gain in first-episode patients
- (2012) Gavin P. Reynolds et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial
- (2012) W. Wolfgang Fleischhacker et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Pharmacogenomic Associations With Weight Gain in Olanzapine Treatment of Patients Without Schizophrenia
- (2012) John P. Houston et al. JOURNAL OF CLINICAL PSYCHIATRY
- Are Antipsychotics or Antidepressants Needed for Psychotic Depression?
- (2012) Arusha Farahani et al. JOURNAL OF CLINICAL PSYCHIATRY
- Association of the Common MC4R rs17782313 Polymorphism With Antipsychotic-Related Weight Gain
- (2012) Fabian Czerwensky et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Genome-wide association studies of obesity and metabolic syndrome
- (2012) Tove Fall et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Pro12Ala
- (2012) Julia Staeker et al. Molecular Diagnosis & Therapy
- Unraveling the brain regulation of appetite: lessons from genetics
- (2012) Giles S H Yeo et al. NATURE NEUROSCIENCE
- Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene
- (2012) N I Chowdhury et al. PHARMACOGENOMICS JOURNAL
- Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain
- (2012) E.J. Brandl et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gain
- (2012) Gwyneth C.M. Zai et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cannabinoid type 1 receptor gene polymorphisms are not associated with olanzapine-induced weight gain
- (2011) Young-Min Park et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Signalling mechanisms of RhoGTPase regulation by the heterotrimeric G proteins G12 and G13
- (2011) T. Kozasa et al. JOURNAL OF BIOCHEMISTRY
- Pharmacogenetics in psychiatry: translating research into clinical practice
- (2011) A K Malhotra et al. MOLECULAR PSYCHIATRY
- Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications
- (2011) T A P Lett et al. MOLECULAR PSYCHIATRY
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
- (2011) Marc De Hert et al. Nature Reviews Endocrinology
- Association Study of Brain-Derived Neurotrophic Factor Gene Polymorphisms and Body Weight Change in Schizophrenic Patients Under Long-Term Atypical Antipsychotic Treatment
- (2011) Ashley Tsai et al. NEUROMOLECULAR MEDICINE
- TNF-α −308 G>A polymorphism and weight gain in patients with schizophrenia under long-term clozapine, risperidone or olanzapine treatment
- (2011) Hsiang-Hsuan Huang et al. NEUROSCIENCE LETTERS
- D2Receptor Genetic Variation and Clinical Response to Antipsychotic Drug Treatment: A Meta-Analysis
- (2010) Jian-Ping Zhang et al. AMERICAN JOURNAL OF PSYCHIATRY
- Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction
- (2010) Jian-Ping Zhang et al. Expert Opinion on Drug Metabolism & Toxicology
- Genetic association between TNF-α −308 G>A polymorphism and longitudinal weight change during clozapine treatment
- (2010) Ying-Chieh Wang et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Association study of polymorphisms in Insulin Induced Gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients
- (2010) Arun K. Tiwari et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- MTHFR genotype and differential evolution of metabolic parameters after initiation of a second generation antipsychotic: an observational study
- (2010) Ruud van Winkel et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Risperidone-Induced Weight Gain in Referred Children with Autism Spectrum Disorders Is Associated with a Common Polymorphism in the 5-Hydroxytryptamine 2C Receptor Gene
- (2010) Pieter J. Hoekstra et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Lack of association between the −759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients
- (2010) Y.-M. Park et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Effect of FTO, SH2B1, LEP, and LEPR Polymorphisms on Weight Gain Associated With Antipsychotic Treatment
- (2010) Rocio Perez-Iglesias et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Endocannabinoid Pro129Thr FAAH Functional Polymorphism But Not 1359G/A CNR1 Polymorphism Is Associated With Antipsychotic-Induced Weight Gain
- (2010) Palmiero Monteleone et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A Common Polymorphism in the Cannabinoid Receptor 1 (CNR1) Gene is Associated with Antipsychotic-Induced Weight Gain in Schizophrenia
- (2010) Arun K Tiwari et al. NEUROPSYCHOPHARMACOLOGY
- Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
- (2010) Steven R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dopamine receptor D2 gene is associated with weight gain in schizophrenic patients under long-term atypical antipsychotic treatment
- (2010) Chen-Jee Hong et al. Pharmacogenetics and Genomics
- DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia
- (2010) Todd Lencz et al. Pharmacogenetics and Genomics
- Association ofHTR2C, but notLEPorINSIG2, genes with antipsychotic-induced weight gain in a German sample
- (2010) Carolin Opgen-Rhein et al. PHARMACOGENOMICS
- Polymorphisms of theHTR2Cgene and antipsychotic-induced weight gain: an update and meta-analysis
- (2010) Michelle N Sicard et al. PHARMACOGENOMICS
- Systematic analysis of dopamine receptor genes (DRD1–DRD5) in antipsychotic-induced weight gain
- (2010) D J Müller et al. PHARMACOGENOMICS JOURNAL
- Association study of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophrenia
- (2010) M R Kuzman et al. PHARMACOGENOMICS JOURNAL
- Absence of weight gain association with the HTR2C −759C/T polymorphism in patients with schizophrenia treated with iloperidone
- (2010) Andrew Thompson et al. PSYCHIATRY RESEARCH
- Polymorphisms of the LEP- and LEPR genes, metabolic profile after prolonged clozapine administration and response to the antidiabetic metformin
- (2010) Erika Fernández et al. SCHIZOPHRENIA RESEARCH
- Antipsychotic drugs and obesity
- (2010) Christoph U. Correll et al. TRENDS IN MOLECULAR MEDICINE
- The Association of Olanzapine-Induced Weight Gain with Peroxisome Proliferator–Activated Receptor-γ2 Pro12Ala Polymorphism in Patients with Schizophrenia
- (2009) Hasan Herken et al. DNA AND CELL BIOLOGY
- Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis
- (2009) Anna C Need et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Association of variants in the PCSK1 gene with obesity in the EPIC-Norfolk study
- (2009) T. O. Kilpelainen et al. HUMAN MOLECULAR GENETICS
- Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
- (2009) Christoph U. Correll JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Multiple Genetic Factors in Olanzapine-Induced Weight Gain in Schizophrenia Patients
- (2009) Hiroshi Ujike et al. JOURNAL OF CLINICAL PSYCHIATRY
- Association of the α2A adrenergic receptor -1291C/G polymorphism and antipsychotic-induced weight gain in European–Americans
- (2009) Laertes Sickert et al. PHARMACOGENOMICS
- Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome
- (2009) B Laika et al. PHARMACOGENOMICS JOURNAL
- Olanzapine-induced weight gain is associated with the −759C/T and −697G/C polymorphisms of the HTR2C gene
- (2009) B R Godlewska et al. PHARMACOGENOMICS JOURNAL
- Leptin Gene –2548G/A variants predict risperidone-associated weight gain in children and adolescents
- (2009) Chadi A. Calarge et al. PSYCHIATRIC GENETICS
- G-protein β3 Subunit Gene 825C/T Polymorphism Is Not Associated with Olanzapine-Induced Weight Gain in Korean Schizophrenic Patients
- (2009) Young-Min Park et al. Psychiatry Investigation
- C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity
- (2009) Mika M. Hirvonen et al. SYNAPSE
- Focus on HTR2C: A possible suggestion for genetic studies of complex disorders
- (2008) Antonio Drago et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Variants Near MC4R Are Associated With Obesity and Influence Obesity-Related Quantitative Traits in a Population of Middle-Aged People: Studies of 14,940 Danes
- (2008) D. P. Zobel et al. DIABETES
- SNAP-25 gene polymorphisms and weight gain in schizophrenic patients
- (2008) Richard Musil et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
- (2008) René S Kahn et al. LANCET
- Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
- (2008) S Le Hellard et al. MOLECULAR PSYCHIATRY
- Common nonsynonymous variants in PCSK1 confer risk of obesity
- (2008) Michael Benzinou et al. NATURE GENETICS
- Common variants near MC4R are associated with fat mass, weight and risk of obesity
- (2008) Ruth J F Loos et al. NATURE GENETICS
- Common genetic variation near MC4R is associated with waist circumference and insulin resistance
- (2008) John C Chambers et al. NATURE GENETICS
- Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes
- (2008) Björn Zethelius et al. NEW ENGLAND JOURNAL OF MEDICINE
- DRD4 48 bp VNTR but not 5-HT2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain
- (2008) J Popp et al. PHARMACOGENOMICS JOURNAL
- Association of antipsychotic induced weight gain and body mass index with GNB3 gene: A meta-analysis
- (2008) Renan P. Souza et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The influence of 5-HT2C and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients
- (2008) Martina Rojnic Kuzman et al. PSYCHIATRY RESEARCH
- Correlation between body mass index and striatal dopamine transporter availability in healthy volunteers—A SPECT study
- (2007) Po See Chen et al. NEUROIMAGE
- Possible association between the −2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain
- (2007) Seung-Gul Kang et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now